Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07526935 · ClinicalTrials.gov registry record · NA
Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator
A NA study, sponsored by Baylor Research Institute.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07526935: Active NA study, sponsored by Baylor Research Institute.
NCT07526935 is a NA study that is active but no longer recruiting, run by Baylor Research Institute. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07526935, a NA study, is active but no longer recruiting, sponsored by Baylor Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is looking at how safe and effective G-POEM, GES and a combination of both are for people with severe stomach problems (gastroparesis) that haven't gotten better with medicine.
Primary Outcome
Monitoring changes in gastroparesis symptom severity as measured by the Gastroparesis Cardinal Symptom Index (GCSI). A 9-item patient reported questionnaire with a rating scale of 0-5 ranging from 0 (none) to 5 (very severe).
Interventions
- DEVICE GES + Upper endoscopy
- DEVICE GES on + Upper endscopy
- PROCEDURE GES off + G-POEM
- PROCEDURE GES on + G-POEM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-03-19 |
| Est. Completion | 2028-12-30 |
| Phase | NA |
What the registry record for NCT07526935 still lists
NCT07526935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which GES + Upper endoscopy is the first listed.
NCT07526935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07526935 about?
NCT07526935 is a clinical study titled "Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator". This study is looking at how safe and effective G-POEM, GES and a combination of both are for people with severe stomach problems (gastroparesis) that haven't gotten better with medicine.
What is the current status of trial NCT07526935?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-03-19. Estimated completion is 2028-12-30.
What interventions are being tested in trial NCT07526935?
The interventions under investigation include: GES + Upper endoscopy (DEVICE), GES on + Upper endscopy (DEVICE), GES off + G-POEM (PROCEDURE), GES on + G-POEM (PROCEDURE).
Who is sponsoring clinical trial NCT07526935?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07526935's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI